OPRX logo

OPRX

OptimizeRx Corporation

$14.59
+$1.01(+7.44%)
29
Overall
40
Value
18
Tech
--
Quality
Market Cap
$299.18M
Volume
259.95K
52W Range
$3.99 - $22.25
Target Price
$24.83

Company Overview

Mkt Cap$299.18MPrice$14.59
Volume259.95KChange+7.44%
P/E Ratio-14.9Open$13.58
Revenue$92.1MPrev Close$13.58
Net Income$-20.1M52W Range$3.99 - $22.25
Div YieldN/ATarget$24.83
Overall29Value40
Quality--Technical18

No chart data available

About OptimizeRx Corporation

OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.

Sector: Technology
Industry: Health Information Services

Latest News

Stifel Nicolaus Remains a Buy on OptimizeRx (OPRX)

In a report released on November 14, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx, with a price target of $24.83. Acco...

TipRanks Auto-Generated Intelligence Newsdesk5 days ago

Stifel Nicolaus Keeps Their Buy Rating on OptimizeRx (OPRX)

TipRanks Auto-Generated Intelligence Newsdesk16 days ago
ABCD
1SymbolPriceChangeVol
2OPRX$14.59+7.4%259.95K
3
4
5
6

Get OptimizeRx Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.